National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts ...

Steven T. Reed, O.D., discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults ...

An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...

(Reuters) -German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals ...

Inherited retinal degenerations (IRDs) are a group of genetic disorders that lead to progressive vision loss as the ...

Age-related macular degeneration (AMD) is a progressive eye disease where the macula – the part of the retina responsible for central vision – ...

A recent study published in the Indian Journal of Ophthalmology has identified significant risk factors for postoperative ...

China’s NMPA approves Eylea 8 mg for wet age-related macular degeneration: Berlin Friday, May 23, 2025, 09:00 Hrs [IST] The Center for Drug Evaluation (CDE) of China’s Nationa ...

Ashvattha Therapeutics reveals promising phase 2 results for migaldendranib, showcasing significant improvements in retinal disease treatment and reduced injection burden.

According to the German Ophthalmological Society (DOG), over 1.5 million eye surgeries are performed annually in the country, ...

They can help a doctor detect any eye complications early and form a treatment plan to reduce the ... complications like diabetic retinopathy and macular edema. This test uses light waves to ...